Filter
359
Filtered Results: 359
Text search:
inactivated
vaccines
Featured
Recommendations
44
New Publications
105
Language
Document type
No document type
174
Guidelines
91
Studies & Reports
39
Manuals
20
Fact sheets
19
Strategic & Response Plan
7
Situation Updates
5
Training Material
3
Resource Platforms
1
Countries / Regions
Global
11
Germany
11
India
11
South Africa
10
Nigeria
8
Latin America and the Carribbean
7
Pakistan
7
Sierra Leone
6
Syria
6
Philippines
6
Ethiopia
6
Nepal
5
Afghanistan
5
Tanzania
5
Kenya
4
Ukraine
4
Chile
4
Uganda
4
Namibia
4
Rwanda
3
Africa
3
Middle East and North Africa
3
Western and Central Europe
3
Russia
3
Yemen
3
Ecuador
3
Myanmar / Burma
3
Malawi
2
Venezuela
2
Congo, Democratic Republic of
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
East and Southern Africa
2
Bangladesh
2
Papua New Guinea
2
Zambia
2
Liberia
2
North Macedonia
1
Colombia
1
Lesotho
1
Turkey
1
Gambia
1
China
1
Niger
1
Peru
1
Zimbabwe
1
Jordan
1
Paraguay
1
Bolivia
1
Argentina
1
Lebanon
1
Brazil
1
Egypt
1
Libya
1
Bhutan
1
Botswana
1
Indonesia
1
Iraq
1
Somalia
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Guidelines
31
COVID-19
21
Drugs & Medical Equipment
17
Vaccine-preventable Diseases
15
Studies & Reports
13
Policies
11
Statistics
10
Immunization
9
Countries
7
Policies & Guidelines HIV & TB
7
General Guidelines
6
Hepatitis
5
Rabies
5
Humanitarian Crisis
5
Disease Prevention & Control
5
Infection Control & Prevention (IPC)
4
Yellow Fever
4
Women & Child Health
4
Information, Education and Communication (IEC)
4
General Guidelines
4
Maternal Health
4
Demograhic Health Surveys DHS
3
WASH
3
HIV & STI
3
Communicable Diseases
2
Paediatrics
2
Child Health
2
Dermatology
2
Diarrhoeal Disease/Cholera
2
Capacity Building
2
Other
2
Respiratory Infections
2
Surgery & Anaesthesia
2
Communicable Diseases
2
NTDs & Others
2
Dengue
2
Neonatal Care
2
Pharmacy & Technology
1
Hand Hygiene
1
Humanitarian Aid
1
Monitoring & Evaluation
1
Cervical Cancer
1
MPOX - Monkeypox
1
Virology
1
Pediatrics
1
NCD
1
Hemorrhagic Fever
1
Community Health
1
Needs Assessment
1
Gynaecology & Obstetrics
1
Non-communicable Diseases
1
Laboratory Quality Assurance
1
Water
1
Reproductive Health
1
Toolboxes
Action Plans, Policies & Response
18
Inactivated COVID-19 Vaccines
13
Immunization Guidelines
11
Communication Material
9
Country specific documents
7
Access & Strategy
7
Booster Doses
7
Vaccination
6
Infection Control General
6
Biontech/Pfizer Comirnaty
6
Essential Medicines & Devices Lists
6
Health Care Systems
6
Outbreak Prevention & Control
5
Laboratory Guidance
5
Vaccination
5
Blood Supply
5
Disease Prevention & Control
5
Context & Facts
5
Situation Reports & Updates
5
IPC
4
Social Worker
4
Public Health
4
Prevention & Preparedness
4
For General Public & Community
4
For Health Worker
4
Physical Distancing
4
Fair Allocation & Ethical Aspects
4
Covaxin
4
Guidelines & Manuals
4
Clinical Aspects & Diagnostics
4
Miscellaneous
4
Infection Control
4
Volunteers
4
Vaccination
4
Treatment Guidelines
3
Assessment & Studies
3
Agriculture & Veterinary
3
Vaccines & Immunization
3
Yellow Fever
3
Children & Adolescents
3
Laboratory & Sampling
3
Scientific & Research Studies
3
Educational Settings
3
Workplace
3
Moderna
3
Rational use of Medicine
3
Studies & Reports
3
Preparedness & Prevention
3
Gynaecology / Obstetrics
2
Ebola Prevention & Control
2
Surveillance
2
Clinical Aspects
2
Clinical Guidelines
2
Key Resources
2
Influenza Prevention & Control
2
Cholera Prevention & Control
2
Health & Refugee
2
Medical professionals
2
Infection Prevention & Hygiene
2
Clinical Aspects
2
COVID-19 Information
2
For Pregnant Women
2
Clinical Guidelines
2
SARS-CoV-2 Variants
2
Vaxzevria (Astra Zeneca)
2
Johnson & Johnson
2
Research & Pipeline
2
Essential Medicines
2
Supply Chain & Store Management
2
General documents One Health
2
General
2
MPOX - Monkeypox
2
MPOX - Monkeypox
2
Clinical Guidelines
2
Assessment & Response
2
Nutrition
2
Reports & Studies Children HIV
2
Context & Facts
2
War & Conflict
1
Public Health
1
Rapid Response
1
Biosafety
1
ART Drug Resistance
1
Male Circumcision
1
Surveillance
1
Clinical Aspects, Treatment & Prevention
1
Europe
1
Treatment & Prevention
1
Yellow Fever Prevention & Control
1
Country specific
1
Prevention & Control
1
Surgery & Rehabilitation
1
Pediatrics
1
Opportunistic Infections
1
WASH
1
Assessment & Response
1
Context, Facts & Travel Advice
1
Dengue
1
Infection Control
1
Hepatitis
1
Namibia
1
HIV
1
Children/Adolescents Mental Disorders
1
Research
1
Ebola
1
Public Health
1
Cholera
1
Workplace
1
General
1
Climate & Health
1
Laboratory
1
Context & Facts
1
Clinical Guidelines
1
Studies
1
Context & Facts, Travel Advice
1
Hand Hygiene
1
Poster & Infographics
1
Risk Communication & Community Engagement
1
Diagnostics & Laboratory Guidance
1
Surveillance & Contact tracing
1
Covid-19 & the One Health Approach
1
Covid-19 & Climate Change
1
For Parents & Children
1
Training, others
1
Country Specific
1
Prison & Detention
1
Medical & Community Masks
1
Hospital Readiness/Essential Health Services
1
COVID-19 Vaccination
1
Non-pharmaceutical interventions (NPIs)
1
Preparedness, Response & Risk Communication
1
Logistics & Supply
1
Genomic sequencing
1
COVAX Initiative
1
Chile
1
Prices and Patents
1
Model Formulary
1
Pharmacy Practice
1
General Guidelines for Rational Use
1
Pharmacovigilance
1
Waste Managment
1
Situation Reports & Updates
1
Zoonoses
1
Infectious Diseases
1
Health Impact & Climate Change
1
Emergency health kits
1
Humanitarian Aid Guidelines
1
MPOX -Monkeybox Prevention & Control
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Information & Education Material (IEC)
1
General Information & Methodology
1
Women
1
Clinical Aspects & Diagnosis
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
Autism
1
Situation Reports & Updates
1
Technical Information
1
Malawi
1
TB & Prisoners
1
Education of students & professionals
1
Training
1
Assessment & Response
1
Research & Access
1
Dengue Prevention & Control
1
Technical Information
1
Clinical Guidelines
1
HIV / AIDS
1
Testing Guidelines
1
TB/HIV Coinfection
1
Chikungunya Prevention & Control
1
Zika Prevention & Control
1
WASH
1
WASH
1
Laboratory
1
Psychosocial Support
1
Paediatrics
1
Marburg Virus Situation Reports
1
Key Resources
1
Preparedness & Prevention
1
Global Health Financing
1
Laboratory & Diagnostics
1
Kenya
1
Pregnant women
1
Meningitis & Encephalitis
1
Public Health
1
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
The current SEARVAP (South-East Asia regional vaccine action plan) describes a set of regional goals and objectives for immunization and control of vaccine-preventable diseases for 2016 – 2020 and highlights priority actions, targets and indicators that address the specific needs and challenges of...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
Updated 28 December 2020
28 Dec 2020. The main objective of these guidelines is to provide tools for staff working in the field of immunization to support effective communication between health personnel and the general population, with the aim of strengthening, maintaining or recovering trust in vaccines and the immunizati...
3 February 2021
Vaccine- and vaccination-related crises require a communication response that is different from the communication strategies used to promote the benefits and importance of vaccines in general. This document presents the technical guidance needed to develop a communication plan that ...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so...
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan...
News Release 11 april 2022
The aim of this article is to identify the elements behind the country’s successful COVID-19 rollout as well as lessons and chal lenges derived from this process. The analysis is relevant to many countries today—as they keep searching for strategies to cope with the second year of the COVID-19 p...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Africa and Asia. Approximately 40% of deaths occur in children.
